Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 390 participants.
Also called NCT01878669
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 390 participants
- Sponsor
- Registry
-
NCT01878669
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Türkiye
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT01878669. Randomized; triple masking; primary purpose prevention. Start 2013-01 (registry gives no type); primary completion 2017-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention
- Acronym
- EASE-PCI
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- N-acetyl cysteine
- Intervention (Drug)
- Saline
- Lead sponsor
- Suleyman Demirel University
Record details
- Record id
cardio:ct-nct01878669- Content hash
d8dbefe2646267c740d40aa57873306e2dbb86c34a8f581a487efac73da99ac9